Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Operating Expenses: 2009-2025

Historic Operating Expenses for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $71.9 million.

  • Prestige Consumer Healthcare's Operating Expenses fell 1.55% to $71.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $291.2 million, marking a year-over-year increase of 1.17%. This contributed to the annual value of $297.7 million for FY2025, which is 5.56% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Operating Expenses stood at $71.9 million for Q3 2025, which was up 4.86% from $68.6 million recorded in Q2 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Operating Expenses peaked at $434.8 million during Q1 2023, and registered a low of $63.2 million during Q4 2022.
  • Moreover, its 3-year median value for Operating Expenses was $71.8 million (2023), whereas its average is $105.0 million.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Operating Expenses skyrocketed by 508.59% in 2023, and later slumped by 83.98% in 2024.
  • Prestige Consumer Healthcare's Operating Expenses (Quarterly) stood at $72.5 million in 2021, then dropped by 12.76% to $63.2 million in 2022, then increased by 12.48% to $71.1 million in 2023, then decreased by 2.84% to $69.1 million in 2024, then fell by 1.55% to $71.9 million in 2025.
  • Its Operating Expenses was $71.9 million in Q3 2025, compared to $68.6 million in Q2 2025 and $81.6 million in Q1 2025.